Design of Glycogen Synthase Kinase-3 Inhibitors: An Overview on Recent Advancements

E-ISSN： 1873-4286|19|26|4755-4775

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.26, 2013-08, pp. : 4755-4775

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glycogen Synthase Kinase-3 - An Overview of An Over-Achieving Protein Kinase

Current Drug Targets, Vol. 7, Iss. 11, 2006-11 ,pp. : 1377-1388

Bentham Science Publishers

Access to resources Recommend Favorite

Vertex inhibitors of Aurora-2, glycogen synthase kinase-3 and Src kinase

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 3, 2004-03 ,pp. : 439-443

Informa Healthcare

Access to resources Recommend Favorite

Glycogen Synthase Kinase 3 as an Anticancer Drug Target: Novel Experimental Findings and Trends in the Design of Inhibitors

Current Pharmaceutical Design, Vol. 19, Iss. 4, 2013-02 ,pp. : 665-679

Bentham Science Publishers

Access to resources Recommend Favorite

Glycogen Synthase Kinase-3 (GSK-3) Inhibitors for the Treatment of Alzheimer's Disease

Current Pharmaceutical Design, Vol. 16, Iss. 25, 2010-08 ,pp. : 2790-2798

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of glycogen synthase kinase-3: future therapy for unmet medical needs?

By Dorronsoro Isabel Castro Ana Martinez Ana

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 10, 2002-10 ,pp. : 1527-1536

Informa Healthcare

Access to resources Recommend Favorite